KTTAPasithea Therapeutics Corp.同业对比
Pasithea Therapeutics Corp. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KTTA本股 | $17M#8 | — | 0.3x#2 | 34.4x#5 | 3130.4%#1 | -46.9%#14 | -4286.7%#7 | -41.0%#3 | — | — | — | — |
| MRKR | $20M#2 | — | 1.6x#6 | 5.5x#2 | -46.2%#6 | -13.3%#8 | -363.5%#3 | -100.0%#7 | -1413.6%#6 | — | 18.6%#2 | — |
| SHPH | $20M#1 | 349.0x#5 | 6.1x#15 | — | — | -28.2%#11 | — | -350.3%#14 | -507.7%#4 | — | -90.3%#10 | — |
| ALLR | $19M#3 | 0.0x#1 | 5.4x#13 | 59.7x#7 | — | 54.2%#1 | -3939.1%#6 | -317.6%#13 | — | — | -18.9%#3 | — |
| BFRI | $18M#4 | — | 3.1x#10 | 0.4x#1 | 11.7%#3 | 40.7%#2 | -27.2%#1 | -176.9%#9 | -712.4%#5 | — | 41.5%#1 | — |
| ARTL | $18M#5 | — | 3.6x#12 | — | — | -31.1%#12 | — | -257.7%#12 | — | — | -97.1%#12 | — |
| PTN | $18M#6 | 89.5x#4 | 1.7x#7 | — | -100.0%#9 | -41.8%#13 | — | 163.3%#2 | -2281.5%#8 | — | — | — |
| LPCN | $17M#7 | — | 0.8x#3 | 8.8x#4 | -82.3%#7 | -96400.0%#16 | -524.7%#4 | -44.2%#4 | -52.6%#1 | — | — | — |
| CTXR | $16M#9 | — | 0.2x#1 | 180.5x#9 | 0.0%#5 | -0.8%#6 | -42806.2%#9 | -59.7%#5 | — | — | -49.9%#6 | — |
| LSTA | $16M#11 | — | 1.9x#8 | 91.7x#8 | -83.0%#8 | 17.0%#5 | -10711.2%#8 | -201.2%#10 | — | 3#1 | -24.5%#4 | — |
| CYCN | $16M#10 | — | 3.1x#11 | 7.6x#3 | 3.7%#4 | -15.4%#9 | -239.8%#2 | -69.4%#6 | -69.1%#2 | — | -77.9%#8 | — |
| ANEB | $15M#12 | — | 1.9x#9 | — | — | -3.5%#7 | — | -106.9%#8 | — | — | -85.1%#9 | — |
| MBRX | $15M#13 | 0.1x#3 | 1.3x#4 | — | — | 28.8%#4 | — | 289.6%#1 | — | — | -92.5%#11 | — |
| HIND | $14M#14 | 0.0x#2 | 5.6x#14 | 44.6x#6 | 24.4%#2 | -609.0%#15 | -3269.4%#5 | -405.7%#15 | -226.2%#3 | — | -72.9%#7 | — |
| ADIL | $14M#15 | — | — | — | — | 39.5%#3 | — | — | — | — | -40.1%#5 | — |
| BIVI | $13M#16 | — | 1.3x#5 | — | — | -25.8%#10 | — | -214.9%#11 | -1671.2%#7 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议